Neonatology Practice Questions

Q: A 32-week premature infant, weighing less than 1 kg and otherwise healthy, presents with jaundice and a serum bilirubin level of 5 mg%. What is the ideal management in this case?

Phototherapy. **Explanation:** The management of neonatal jaundice in preterm infants depends on birth weight, gestational age, and clinical stability. In this case, the infant is **extremely low birth weight (ELBW <1000g)** and premature (32 weeks). **1. Why Phototherapy is Correct:** Preterm infants are at a significantly higher risk of bilirubin encephalopathy (Kernicterus) at much lower bilirubin levels than term infants due to an immature blood-brain barrier and lower serum albumin levels. For an infant weighing **<1000g**, the threshold to initiate phototherapy is very low—typically starting at **5 mg/dL** or even prophylactic phototherapy in some protocols. This "aggressive" approach prevents the bilirubin from reaching levels that would require invasive exchange transfusion. **2. Why Other Options are Incorrect:** * **Observation:** While 5 mg% is normal for a term baby, it is the treatment threshold for an ELBW infant. Delaying treatment risks neurotoxicity. * **Medical Management:** Drugs like Phenobarbitone (to induce glucuronosyltransferase) take 48–72 hours to work and are not indicated for acute management of neonatal jaundice. * **Exchange Transfusion:** This is a high-risk procedure reserved for cases where bilirubin levels are dangerously high (typically >10–15 mg/dL in this weight category) or when intensive phototherapy fails. **Clinical Pearls for NEET-PG:** * **Rule of Thumb for Preterms:** A common clinical guide for starting phototherapy in stable preterms is **1% of birth weight** (e.g., 5 mg/dL for 500g, 10 mg/dL for 1000g). However, for ELBW infants ( 5 mg/dL/day, or exceeds 15 mg/dL. * **Most common cause** of jaundice requiring exchange transfusion is Rh isoimmunization.

Q: What should be measured in a newborn who presents with hyperbilirubinemia?

Total and direct bilirubin. In neonatology, the initial evaluation of jaundice must differentiate between **unconjugated (indirect)** and **conjugated (direct)** hyperbilirubinemia, as their clinical implications and management strategies differ fundamentally. ### **Why Total and Direct Bilirubin is Correct** Measuring both values is essential to calculate the **indirect fraction** (Total Bilirubin minus Direct Bilirubin). 1. **Indirect Hyperbilirubinemia:** Most common in newborns (e.g., physiological jaundice, hemolysis, breast milk jaundice). It carries the risk of **kernicterus** (bilirubin encephalopathy) because unconjugated bilirubin is lipid-soluble and can cross the blood-brain barrier. 2. **Direct Hyperbilirubinemia:** Defined as a direct bilirubin >1 mg/dL (if TSB 20% of TSB. This is always **pathological** and suggests cholestasis (e.g., Biliary Atresia, Neonatal Hepatitis), requiring urgent surgical or medical intervention. ### **Why Other Options are Incorrect** * **Total Bilirubin only:** Fails to identify cholestasis. A high total bilirubin could mask a significant direct component that requires a completely different diagnostic workup. * **Direct/Conjugated Bilirubin only:** These do not provide the total load of bilirubin, making it impossible to determine the risk of neurotoxicity or the need for phototherapy/exchange transfusion. ### **NEET-PG High-Yield Pearls** * **Pathological Jaundice:** Suspect if jaundice appears within the **first 24 hours** of life, TSB rises >5 mg/dL/day, or persists >2 weeks in term infants. * **Kramer’s Rule:** Used for clinical estimation of jaundice (Face: ~5 mg/dL; Soles: >15 mg/dL). * **Biliary Atresia:** The most common cause of neonatal cholestasis; the **Kasai procedure** is most effective if performed before 60 days of life. * **Phototherapy:** Converts bilirubin into water-soluble **lumirubin** via structural isomerization (irreversible).

Q: What is the lifespan of RBCs in a premature neonate?

40 days. **Explanation:** The lifespan of Red Blood Cells (RBCs) in neonates is significantly shorter than in adults due to several physiological factors. In a **premature neonate**, the RBC lifespan is approximately **35 to 50 days (average 40 days)**. **Why is the lifespan shorter?** 1. **Metabolic Factors:** Neonatal RBCs have lower levels of intracellular enzymes (like phosphofructokinase) and reduced ATP levels. 2. **Oxidative Stress:** They are more susceptible to lipid peroxidation and oxidative damage. 3. **Membrane Properties:** The RBC membrane in neonates is less deformable, leading to earlier sequestration and destruction in the splenic microcirculation. **Analysis of Options:** * **Option A (120 days):** This is the normal RBC lifespan in **adults** and older children. * **Option B (60 days):** This is the approximate lifespan of RBCs in a **term neonate** (range 60–90 days). * **Option C (90 days):** This represents the upper limit for a term neonate but is too long for a premature infant. * **Option D (40 days):** This is the standard accepted value for **premature neonates**, reflecting their extreme physiological immaturity. **NEET-PG High-Yield Pearls:** * **Physiological Anemia of Infancy:** Occurs around 8–12 weeks in term infants (Hb ~11 g/dL). * **Anemia of Prematurity:** Occurs earlier (3–6 weeks) and is more severe (Hb ~7–9 g/dL) due to the shorter RBC lifespan (40 days) and impaired erythropoietin response. * **Fetal Hemoglobin (HbF):** Comprises 60–80% of total hemoglobin at birth; it has a higher affinity for oxygen but shifts the oxygen dissociation curve to the left.

Q: The clinical sign of hyaline membrane disease generally first appears?

In the first 6 hours of life. **Explanation:** **Hyaline Membrane Disease (HMD)**, also known as Respiratory Distress Syndrome (RDS), is caused by a deficiency of pulmonary surfactant in preterm infants. Surfactant is essential for reducing surface tension and preventing alveolar collapse at the end of expiration. **Why Option A is Correct:** The clinical manifestations of HMD typically begin **at birth or within the first 6 hours of life**. As the infant begins to breathe, the lack of surfactant leads to progressive atelectasis. This results in the classic triad of respiratory distress: tachypnea, prominent chest retractions (subcostal/intercostal), and an expiratory grunt. Because the underlying pathology is a structural deficiency present at delivery, symptoms do not wait for 12 or 24 hours to manifest. **Why Other Options are Incorrect:** * **Options B, C, and D:** If a neonate is asymptomatic for the first 12–24 hours and then develops respiratory distress, clinicians should look for alternative diagnoses such as **Group B Streptococcal sepsis**, pneumonia, or late-onset complications. HMD that presents after 24–48 hours is highly atypical, as the disease usually peaks at 48–72 hours and begins to improve thereafter due to endogenous surfactant production. **Clinical Pearls for NEET-PG:** * **Chest X-ray Findings:** Characterized by a "Ground Glass Appearance" and "Air Bronchograms." * **Risk Factors:** Prematurity (most common), maternal diabetes, cesarean section without labor, and being the second-born of twins. * **Prevention:** Antenatal corticosteroids (e.g., Betamethasone) given to the mother 24–48 hours before preterm delivery. * **Management:** Early CPAP is the preferred initial intervention; exogenous surfactant replacement is the definitive treatment.

Q: Neonatal seizures carry the best prognosis if the cause is:

Hypocalcemia. The prognosis of neonatal seizures is primarily determined by the underlying etiology rather than the seizure type or duration. ### **Why Hypocalcemia is the Correct Answer** Hypocalcemia (specifically **late-onset hypocalcemia**, occurring after 72 hours of life) carries the **best prognosis**, with normal neurodevelopmental outcomes in nearly **100% of cases**. This is because the seizures are caused by a transient metabolic disturbance (often due to high phosphate intake from cow’s milk) rather than structural brain damage. Once calcium levels are corrected, the seizures typically resolve without leaving any permanent neurological deficit. ### **Why Other Options are Incorrect** * **Idiopathic:** While "benign familial neonatal seizures" have a good prognosis, the term "idiopathic" is broad. Metabolic causes like hypocalcemia have a more definitively positive outcome compared to cases where the cause remains unknown. * **Infection (Meningitis/Encephalitis):** These carry a guarded prognosis (30-50% risk of sequelae) due to direct inflammatory damage to the brain parenchyma, leading to scarring, hydrocephalus, or infarcts. * **Asphyxia (HIE):** Hypoxic-Ischemic Encephalopathy is the **most common cause** of neonatal seizures but carries a **poor prognosis**. It often leads to permanent neurological disabilities, including cerebral palsy and intellectual impairment. ### **NEET-PG High-Yield Pearls** * **Most common cause of neonatal seizures:** Hypoxic-Ischemic Encephalopathy (HIE). * **Best prognosis:** Late-onset hypocalcemia. * **Worst prognosis:** Early-onset seizures due to congenital malformations of the brain or severe HIE. * **Drug of choice (DOC):** Phenobarbitone (20 mg/kg loading dose). * **Most common seizure type in neonates:** Subtle seizures (e.g., eye blinking, rowing movements, apnea).

Question 1

A 32-week premature infant, weighing less than 1 kg and otherwise healthy, presents with jaundice and a serum bilirubin level of 5 mg%. What is the ideal management in this case?

Accepted Answer

Phototherapy

Answer

Observation

Answer

Medical management

Answer

Exchange transfusion

Question 2

What differentiates secondary apnea from primary apnea in a newborn?

Accepted Answer

Clinically, primary and secondary apnea are indistinguishable.

Answer

Simple stimulation reverses it.

Answer

Accompanied by loss of neuromuscular tone.

Answer

Will spontaneously resume respiratory efforts.

Question 3

What should be measured in a newborn who presents with hyperbilirubinemia?

Accepted Answer

Total and direct bilirubin

Answer

Total bilirubin only

Answer

Direct bilirubin only

Answer

Conjugated bilirubin only

Question 4

What is the lifespan of RBCs in a premature neonate?

Accepted Answer

40 days

Answer

120 days

Answer

60 days

Answer

90 days

Question 5

A 3-5 day old neonate presents with a complaint. Which of the following presentations requires further investigation?

Accepted Answer

Tachypnea and grunting

Answer

Vaginal bleeding

Answer

Hymenal tags

Answer

Subconjunctival hemorrhage

Question 6

The clinical sign of hyaline membrane disease generally first appears?

Accepted Answer

In the first 6 hours of life

Answer

Between 12 and 24 hours of life

Answer

Between 36 and 48 hours of life

Answer

After 48 hours of life

Question 7

Which of the following statements about newborn assessment is NOT true?

Accepted Answer

APGAR score at 7 minutes indicates neonatal mortality depression.

Answer

APGAR score at 1 minute is an indicator for neonatal resuscitation.

Answer

A fetus can rapidly wash out CO2 through the placenta.

Answer

Anaerobic metabolism causes acidemia.

Question 8

Which of the following is the most important risk factor in the etiology of intraventricular hemorrhage (IVH) in neonates?

Accepted Answer

Extreme prematurity

Answer

Coagulation disorder

Answer

Continuous Positive Airway Pressure

Answer

Pneumothorax

Question 9

A child presents with lethargy and hypotonia 12 hours after birth, following resuscitation. There have been two episodes of seizures. What is the stage of hypoxic-ischemic encephalopathy (HIE)?

Accepted Answer

Stage 2B

Answer

Stage 2C

Answer

Stage 1A

Answer

Stage 3

Question 10

Neonatal seizures carry the best prognosis if the cause is:

Accepted Answer

Hypocalcemia

Answer

Idiopathic

Answer

Infection

Answer

Asphyxia

Neonatology — MCQs

Neonatology — MCQs

On this page

Practice by Chapter

Want unlimited practice?